학술논문
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
Document Type
Article
Author
Source
Cancer Reports; Apr2024, Vol. 7 Issue 4, p1-6, 6p
Subject
Language
ISSN
25738348